Table II.
Hub gene | Overall survival associated | Recurrence-free survival associated | Clear cell renal cell carcinoma versus normal kidney tissue |
---|---|---|---|
KIF23 | √a | ||
CDKN3 | √ | √ | Upregulated |
TPX2 | √ | √ | Upregulated |
BUB1B | √ | √ | Upregulated |
CDCA8 | √ | √ | Upregulated |
UBE2C | √ | √ | Upregulated |
NDC80 | √ | √ | Upregulated |
KIF15 | |||
PBK | Upregulated | ||
MELK | √ | Upregulated | |
RRM2 | √ | √ | Upregulated |
DLGAP5 | Upregulated | ||
NCAPG | √ | √ | Upregulated |
EXO1 | |||
NUF2 | √ | Upregulated | |
NCAPH | √ | √ | Upregulated |
KIF18A | √ | ||
PTTG1 | √ | √ | Upregulated |
FAM64A | √ | √ | Upregulated |
ANLN | √ | √ | Upregulated |
SHCBP1 | |||
CENPE | √ | ||
MCM10 | |||
MKI67 | Upregulated | ||
KIF14 | √ | ||
HMMR | √ | Upregulated | |
KIF4A | √ | √ | Upregulated |
CEP55 | √ | √ | Upregulated |
CENPF | √ | √ | Upregulated |
KIF20A | √ | √ | Upregulated |
CDC45 | √ | Upregulated | |
ASPM | √ | √ | Upregulated |
NEK2 | √ | Upregulated | |
TTK | √ | ||
HJURP | √ | √ | Upregulated |
√. P<0.05; P<0.001 and |log2Fold-change|>0.585.